Copper drug clears toxic Alzheimer’s proteins and restores memory
A copper-based compound has been shown to enhance the brain's ability to remove toxic amyloid proteins linked to Alzheimer's disease, significantly reducing their buildup and improving memory in laboratory tests. The drug, which has already been tested in humans for other neurological conditions, may offer a faster path to new treatments by targeting a key waste-removal system in the brain. Researchers found that the compound increases the activity of transport proteins that help clear harmful waste, potentially restoring brain function. This discovery suggests a new therapeutic approach for Alzheimer's by addressing neurovascular dysfunction.
A copper-based drug helped clear toxic Alzheimer’s proteins and improved memory in lab tests by repairing the brain’s waste-removal system.
This discovery could lead to faster development of new Alzheimer’s treatments since the drug has already been tested in humans for other conditions.
It offers hope for more effective, safer therapies by addressing a key cause of Alzheimer’s and building on existing medical research.
Upbeat Bytes summarizes in its own words and links to the original publisher — it doesn't host the article.